Senior insider sale
Chief Accounting Officer at C4 THERAPEUTICS, INC. — senior position signals high conviction
$35.5K
9.09K shares
What this filing means
MOSSLER MARK plans to sell 9.09K shares of C4 THERAPEUTICS, INC. valued at approximately $35.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/29/2026ACC: 0001193125-26-245847
Officer· Chief Accounting Officer
Since Feb 2026
9.09K
Shares to sell
$35.5K
Approx. market value
29.08K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Grant under Issuer's 2020 Equity Incentive Plan
These securities were acquired pursuant to an option grant under the Issuer's 2020 Equity Incentive Plan. 29,080 options were granted on February 14, 2025, of which 9,087 vested and were exercised and sold pursuant to a same-day sale transaction.
2/14/2025
29.08KTotal acquired29.08K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/14/2025 | Grant under Issuer's 2020 Equity Incentive Plan These securities were acquired pursuant to an option grant under the Issuer's 2020 Equity Incentive Plan. 29,080 options were granted on February 14, 2025, of which 9,087 vested and were exercised and sold pursuant to a same-day sale transaction. | 29.08K | — |
| Total | 29.08K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
9.09K
Market value
$35.5K
5/27/2026
Total
Units
9.09K
Value
$35.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/27/2026 | 9.09K | $35.5K | Nasdaq | Planned |
| Total | 9.09K | $35.5K | ||